Blood cell function and stress in pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how blood cells work and handle stress in people with certain types of pulmonary hypertension. By understanding these processes, doctors hope to improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with a specific type of high blood pressure in the lungs (pre-capillary pulmonary hypertension), confirmed by a heart catheterization test.
- Your condition falls into one of three groups: Group 1 (PAH), Group 3 (from lung disease), or Group 4 (from blood clots in the lungs).
- You are scheduled for a routine visit or a heart catheterization at the study center.
- You are willing to give consent to take part and allow your medical data to be used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether people with certain blood disorders (myeloproliferative neoplasms) have higher rates of high blood pressure in the lungs and reduced right heart function. By using an ultrasound of the heart, researchers hope to learn more about these complications and potentially improve monitoring and care.
This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.
This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.
This study looks at special chemicals in the blood (metabolites) from people with both lung scarring and high lung blood pressure. It aims to learn how these chemicals change with or without treatment for the lung blood pressure.
This study looks at how your heart and lungs respond to starting a blood vessel–widening medication (a vasodilator) for pulmonary hypertension. It will closely monitor your breathing and heart rhythm to help doctors understand and improve treatment.
This study looks at lung tissue from surgery to learn how pulmonary hypertension (high blood pressure in the lungs) develops in people with lung disease. The goal is to find better ways to diagnose and treat this condition.
Hear when a new Pre-capillary Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.